Adaptive Radiotherapy for an Uncommon Chloroma

Granulocytic sarcomas, also referred to as chloromas or myeloid sarcomas, are extramedullary neoplasms that are composed of immature myeloid cells. This uncommon disease is known to be radiosensitive. However, the total dose and dose per fraction are not standardized. In addition, during the course...

Descripción completa

Detalles Bibliográficos
Autores principales: Majdoul, Soufya, Colson-Durand, Laurianne, To, Nu Hanh, Belkacemi, Yazid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118684/
https://www.ncbi.nlm.nih.gov/pubmed/27920690
http://dx.doi.org/10.1159/000450599
_version_ 1782468972336119808
author Majdoul, Soufya
Colson-Durand, Laurianne
To, Nu Hanh
Belkacemi, Yazid
author_facet Majdoul, Soufya
Colson-Durand, Laurianne
To, Nu Hanh
Belkacemi, Yazid
author_sort Majdoul, Soufya
collection PubMed
description Granulocytic sarcomas, also referred to as chloromas or myeloid sarcomas, are extramedullary neoplasms that are composed of immature myeloid cells. This uncommon disease is known to be radiosensitive. However, the total dose and dose per fraction are not standardized. In addition, during the course of radiation therapy, significant reduction of the tumor is usually obtained. Thus, target volume reduction may require an intermediate radiotherapy plan evaluation for an adaptive treatment. A second plan at mid-dose is highly recommended.
format Online
Article
Text
id pubmed-5118684
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-51186842016-12-05 Adaptive Radiotherapy for an Uncommon Chloroma Majdoul, Soufya Colson-Durand, Laurianne To, Nu Hanh Belkacemi, Yazid Case Rep Oncol Case Report Granulocytic sarcomas, also referred to as chloromas or myeloid sarcomas, are extramedullary neoplasms that are composed of immature myeloid cells. This uncommon disease is known to be radiosensitive. However, the total dose and dose per fraction are not standardized. In addition, during the course of radiation therapy, significant reduction of the tumor is usually obtained. Thus, target volume reduction may require an intermediate radiotherapy plan evaluation for an adaptive treatment. A second plan at mid-dose is highly recommended. S. Karger AG 2016-10-12 /pmc/articles/PMC5118684/ /pubmed/27920690 http://dx.doi.org/10.1159/000450599 Text en Copyright © 2016 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Majdoul, Soufya
Colson-Durand, Laurianne
To, Nu Hanh
Belkacemi, Yazid
Adaptive Radiotherapy for an Uncommon Chloroma
title Adaptive Radiotherapy for an Uncommon Chloroma
title_full Adaptive Radiotherapy for an Uncommon Chloroma
title_fullStr Adaptive Radiotherapy for an Uncommon Chloroma
title_full_unstemmed Adaptive Radiotherapy for an Uncommon Chloroma
title_short Adaptive Radiotherapy for an Uncommon Chloroma
title_sort adaptive radiotherapy for an uncommon chloroma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118684/
https://www.ncbi.nlm.nih.gov/pubmed/27920690
http://dx.doi.org/10.1159/000450599
work_keys_str_mv AT majdoulsoufya adaptiveradiotherapyforanuncommonchloroma
AT colsondurandlaurianne adaptiveradiotherapyforanuncommonchloroma
AT tonuhanh adaptiveradiotherapyforanuncommonchloroma
AT belkacemiyazid adaptiveradiotherapyforanuncommonchloroma

Ejemplares similares